Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Isotec is a leading supplier of stable isotopes and isotope-labeled compounds for the life science research, diagnostic, and industrial markets. As a specialized division within MilliporeSigma, the life science business of Merck KGaA, Isotec provides high-purity materials labeled with Carbon-13, Nitrogen-15, and Deuterium. These products are critical for applications such as metabolic profiling, protein structure determination via NMR, and clinical diagnostics, including the urea breath test for Helicobacter pylori. The company operates one of the world's largest commercial isotope separation plants, utilizing cryogenic distillation to produce essential isotopes. Isotec's extensive catalog supports researchers in drug discovery, proteomics, and environmental science globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Isotec.